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Citrinin (CTN) is a nephrotoxic mycotoxin produced by several fungal strains belonging to the genera 
Penicillium, Aspergillus, and Monascus. It contaminates various commodities of plant origin, cereals 
in particular, and is usually found together with another nephrotoxic mycotoxin, ochratoxin A (OTA). 
These two mycotoxins are believed to be involved in the aetiology of endemic nephropathy. In addition 
to nephrotoxicity, CTN is also embryocidal and fetotoxic. The genotoxic properties of CTN have been 
demonstrated with the micronuleus test (MN), but not with single-cell gel electrophoresis. The mechanism 
of CTN toxicity is not fully understood, especially not whether CTN toxicity and genotoxicity are the 
consequence of oxidative stress or of increased permeability of mitochondrial membranes. CTN requires 
complex cellular biotransformation to exert mutagenicity.
Compared with other mycotoxins, CTN contamination of food and feed is rather scarce. However, it is 
reasonable to believe that humans are much more frequently exposed to CTN than generally accepted, 
because it is produced by the same moulds as OTA, which is a common contaminant of human food all 
over the world.
At present, there are no specifi c regulations either in Croatia or in the European Union concerning CTN 
in any kind of commodity.
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Citrinin (CTN, Figure 1) is a secondary product 
of fungal metabolism, fi rst isolated by Hetherington 
and Raistrick from a culture of Penicillium citrinum 
Thom (1). Meanwhile, several other fungal species 
within the three genera, Penicillium (P. expansum, P. 
verrucosum), Aspergillus (A. terreus), and Monascus 
(M. ruber) were also found to produce this mycotoxin 
(2, 3). CTN contaminates maize (4), wheat, rye, 
barley, oats (5), and rice (6). Strains of Monascus are 
traditionally used in China to produce red and yellow 
pigments for food (7). Western countries limit the use 
of synthetic food colorants due to their toxicity and 
mutagenicity. Natural food pigments obtained from 
Monascus were good candidates for their substitution 
because reports on their toxic effects had been scarce 
for more than 1000 years. However, in 1981 Wong 
and Koehler (8) isolated from Monascus purpureus a 
pale yellow pigment monascidin A, which was later 
determined to be CTN (9). An analysis of traditional 
Chinese commercial Monascus products obtained by 
culturing the fungus on steamed rice determined CTN 
in all samples in the mass fraction range of 0.2 µg g-1 
to 17.1 µg g-1 (10).
CTN is decomposed at 175 °C by dry heating, 
but decomposition temperature decreases to 140 °C 
in the presence of a small amount of water (11, 12). 
Decomposition products obtained by heating CTN 
with water at 140 °C to 150 °C were as toxic as or 





(12). The concentration of CTN in the 
extract of Monascus decreases by 50 % after boiling 
in water for 20 minutes, which proves that CTN is 
thermally unstable in aqueous solution (13).
As there are no legal requirements to measure 
CTN in food and feed and as probably citrinin H
1
 is 
not detectable by usual methods due to its dimeric 
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structure, data on food contamination with CTN are 
scarce. Table 1 shows data for CTN contamination of 
some common foodstuffs.
CTN has antibiotic properties against gram-
positive bacteria, but it has never been used as a 
drug due to its high nephrotoxicity. The kidney is 
the major target organ of CTN toxicity, but other 
target organs such as liver and bone marrow have 
also been reported (21). Historically, CTN is one of 
the fi rst isolated mycotoxins; however, the data on 
the mechanism of its toxicity are still controversial 
and most have been obtained in vitro. Like other 
mycotoxins, CTN could be implicated in porcine 
nephropathy (14). It is frequently found in food and 
feed in combination with ochratoxin A (OTA), and 
these two nephrotoxic mycotoxins are suspected to be 
involved in the aetiology of a human kidney disease 
called Balkan endemic nephropathy. In the endemic 
area in Bulgaria, CTN was more common and had 
higher concentrations in maize and beans intended 
for human consumption than in the non-endemic area 
(22). CTN was also found to increase the toxicity of 
OTA either additively or synergistically (23).
The International Agency for Cancer Research 
(IARC) classifi ed CTN in Group 3 of carcinogens 
because of the limited evidence of its carcinogenicity 
to experimental animals and no evidence for humans 
(24).
Analytical methods for CTN determination were 
recently reviewed (12). Common methods for CTN 
analysis are thin-layer chromatography (TLC), high-
performance liquid chromatography (HPLC) with UV 
or fl uorescence detection, and enzyme immunoassays. 
For qualitative and quantitative determination of CTN 
LC-MS and GC-MS techniques are used.
TOXICITY, CARCINOGENICITY, AND 
TERATOGENICITY
The cytotoxicity of CTN varies remarkably from 
one cell culture to another (Table 2). CTN applied on 
cultured hepatoma cells at doses up to 25 μmol L-1 was 
cytostatic, while at concentrations from 50 μmol L-1 
to 200 μmol L-1 it was cytotoxic (29). The effect of 
CTN on cell viability was tested with the MTT assay 
on Vero cells from the green monkey kidney treated 
with increasing CTN concentrations from 0 μmol L-
1 to 250 μmol L-1 (28). Up to the concentration of 
60 μmol L-1 no signifi cant change in cell viability 
was observed, and the estimated IC
50
 of citrinin was 
about 220 μmol L-1 after 48 hours of exposure. With 
the same exposure time, the IC
50
 of CTN for human 
embryonic cell line was 120 μmol L-1. At 24 hours of 
exposure, the IC
50
 of CTN for human promyelocytic 
leukaemia (HL-60) cells and porcine kidney PK15 




 of CTN varies with the route of 
administration, physiological conditions, and animal 
species (Table 3). Oral LD
50
 for rats is 50 mg kg-1 
b.w. (30), while subcutaneous LD
50
 is 67 mg kg-1 b.w. 
(31). The subcutaneous treatment of pregnant rats with 
35 mg kg-1 on days 6, 9, and 10 of pregnancy resulted 
in 50 % or higher maternal mortality (32). In the Dutch 
Belted rabbit, oral LD
50 
is 134 mg kg-1, and in the New 
Zealand White rabbit it is about 120 mg kg-1 (33, 34). 
Acute lethal doses administered to rabbits, guinea 
pigs, rats, and swine caused swelling of the kidneys 
and acute tubular necrosis (36-38).
Subchronical oral treatment of rats with water 
suspension isolated from a strain of Penicillium 
viridicatum Westling caused CTN-induced kidney 
damage characterised by enlarged kidney, hydropic 
degeneration, loss of brush border, and pyknotic 
nuclei in the proximal tubules (36). Treatment of 
mice with weekly injections of CTN (20 mg kg-1) for 
six weeks resulted in a signifi cant decrease in total 
bone marrow cells, red blood cell precursors, white 
blood cell precursors, megakaryocytes, decrease in 
spleen weight, and decrease in the total spleen cell 
count (39).
Data on CTN carcinogenicity in the available 
literature are rather scarce. Kanisawa (40) did not fi nd 
that CTN caused tumours in mice exposed for to CTN 
(0 mg kg-1, 100 mg kg-1, and 200 mg kg-1) through diet 
for 70 weeks, while Arai and Hibino (41) reported 
benign tumours in the kidney of male Fisher 344 rats 
after CTN treatment for 60 and 80 weeks.Figure 1 Structural formula of citrinin
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CTN is embryocidal and foetotoxic in mice 
(42). In pregnant Sprague-Dawley rats, CTN given 
subcutaneously (35 mg kg-1 b.w.) on gestation day 3 
to 15 did not decrease the number of implants and no 
gross or skeletal malformations were found, but the 
foetuses were about 22 % smaller than control (32). 
CTN injected to pregnant rats of the same strain at a 
dose of 30 mg kg-1 on gestation days 5 to 14 resulted 
in a few foetal resorptions and minimal malformations 
(43). The LD
50
 of CTN in a 4-day old chicken embryo 
is 80.5 μg per egg (upper limit of 131 μg, lower limit of 
54.3 μg) (2). CTN doses of 50 μg, 100 μg, and 150 μg 
per egg, were teratogenic in 46 %, 48 %, and 73 % of 
surviving chicken embryos, respectively.
EFFECTS ON RENAL FUNCTION AND 
STRUCTURE
In a study by Jordan et al., a single intraperitoneal 
(i.p.) dose of 50 mg kg-1 CTN caused nephrosis in 
Sprague-Dawley rats (44). Over the fi rst 48 hours, 
urine glucose and blood concentrations increased, 
reaching peak three hours after treatment. Kanisawa 
found that exposure of male mice to 200 mg kg-1 CTN 
through feed for 70 weeks caused very mild renal 
lesions, but not renal tumours (40).
Citrinin given for six weeks in a daily dose of 
2.5 mg kg-1 and 5.0 mg kg-1 in gelatine capsules did not 
cause clinical or pathological changes in the kidney of 
young beagle dogs (45). Slow intravenous injection of 
20 µmol kg-1 CTN to dogs did not affect renal tissue 
ultrastructure or any of 23 whole blood, plasma, or renal 
function parameters that were monitored for six hours 
after treatment (46). On the other hand, 80 µmol kg-1 
of CTN signifi cantly increased hematocrit and renal 
excretion rates of proteins and glucose while modest 
reductions were noted in C
in
 (clearance of inulin), renal 
blood fl ow, and elimination of inorganic phosphorus. 
This dose induced ultrastructural lesions in the cells of 
the S2 proximal tubular segment, the thick ascending 
limb, the distal convoluted tubule, and the collecting 
ducts. The glomeruli, S1 and S3 cells of the proximal 
tubule, and the thin descending and ascending limbs 
of Henle’s loop remained unaffected.
In male New Zealand white rabbits, oral CTN 
dose of 120 mg kg-1 b.w. produced azotaemia and 
metabolic acidosis with haemoconcentration and 
hypokalaemia within 4 to 12 h (34). In surviving 
rabbits, oral doses of 80 mg kg-1 and 100 mg kg-1 
decreased creatinin clearance which reached the peak 
on days 2 to 4, and returned to normal or near normal 
by day 7. In a more recent ultrastructural assessment 
of young growing New Zealand white rabbits exposed 
to 15 mg kg-1 of CTN through feed, most lesions were 
observed in the proximal convoluted tubule lining 
cells, but distal convoluted tubules were unaffected 
(47). CTN treatment induced nucleus crenation, loss 
of nucleolus, depletion of cytoplasmic organelles, 
mitochondrial pleomorphism, nuclear fragmentation, 
uniform folding of cell membrane, and cytoplasmic 
vacuolation in proximal convoluted tubules.
In rat liver catalase, butylhydroxitoluene, and 
dithiothreitol did not protect against swelling and 
against increased mitochondrial permeability caused 
by Ca2+ plus citrinin (48). Protection conferred 
by ATP-Mg2+ and cyclosporine A indicates pore 
formation.
Table 1 Natural occurrence of citrinin in commodities intended for human consumption
Commodity 
contaminated
Mass fraction of citrinin 
μg kg-1
Country References





















Tomatoes 70 to 760 Canada 18
Maize 12 India 19
Fermented maize 580 Ghana 20
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DISTRIBUTION, METABOLISM, AND 
MECHANISMS OF TOXICITY
The target organ of CTN toxicity is the kidney, but 
hepatotoxicity has also been reported (37, 49). The 
distribution of 14C-CTN (3 mg kg-1) was studied in the 
liver, kidney, and plasma of rats sacrifi ced at 10 time 
points after treatment (50). At 0.5 h after treatment, 
14.7 % and 5.6 % of total radioactivity was found in 
the liver and kidney, respectively. At 6 h, these values 
decreased to 7.5 % in the liver and 4.7 % in the kidney. 
Plasma half-lives were 2.6 h and 14.9 h, respectively. 
Most of the radioactivity (approx. 80 %) was found 
in the urine (74 %) and faeces (4 %) in the fi rst 24 
h after treatment. At 72 h after treatment, 95 % of 
radioactivity was excreted via urine and faeces.
The major urinary metabolite of CTN is 
dihydrocitrinone (51). However, CTN as parent 
compound and not its metabolite was responsible for 
nephrotoxicity (52). CTN is an organic anion and its 
effect on renal transport was studied on renal cortical 
slices of animals treated with a single i.p. injection of 
55 mg kg-1 14C-CTN. Animals were killed 72 h after 
dosing, when the effect on renal tubular transport was 
expected to be the highest. The importance of anion 
transport system was demonstrated by the reduced 
uptake of 14C-CTN in the presence of probenecid, a 
specifi c inhibitor of anion transport (53).
In vitro studies on various cultured cells gave 
contradictory results about the involvement of 
oxidative stress in CTN toxicity. Ribeiro et al. reported 
that CTN modifi ed antioxidative enzymatic defences 
of rat liver cells by inhibiting GSSG-reductase and 
transhydrogenase (54). However, no effect was 
observed on GSH-peroxidase, catalase, glucose 6-
phosphate, 6-phosphoguconate dehydrogenase, and 
superoxide dismutase. CTN increased formation of 
reactive oxygen species, stimulating the production of 
superoxide anion in the respiratory chain. The authors 
concluded that oxidative stress was an important 
mechanism in CTN-induced citotoxicty and cellular 
death in several tissues.
The importance of oxidative stress in CTN toxicity 
was confi rmed by microarray studies of CTN effects of 
citrinin in yeast cells (55) and of the viability of Vero 
cells exposed to CTN and antioxidant vitamin E (56). 
Aleo et al. (57) used suspensions of renal proximal 
tubules (RPT) and found that CTN increased lipid 
peroxidation and that deferoxamine (which prevents 
iron-mediated lipid peroxidation) did not protect 
RPT from CTN-induced cell death. The possibility 
that CTN may alter mitochondrial function, put 
forward by this group of authors, was corroborated by 
studies with baby hamster kidney cells (58). Electron 
microscopy showed that CTN signifi cantly affected 
normal mitochondria with swelling and cell death. 
Chagas et al. have suggested that CTN decreases Ca2+ 
accumulation in the matrix by inhibiting its infl ux and 
increasing its effl ux (59).
CTN was found to cause apoptosis in human 
promyelocytic leukemia (HL-60) cells and porcine 
kidney PK15 cells (26, 27). The number of apoptotic 
cells increased dramatically at doses higher than LC
50 
(50 μg). CTN induced dose-dependent formation of 
caspases 3, 6, 7, and 9, but not caspase 8. Furthermore, 
the authors noted increased cytochrome c release from 
mitochondria into the cytoplasm, and cytochrome c 
is known to activate apoptosis-regulating caspases 3, 
6, 7, and 9. This suggests that CTN induces apoptosis 
through cytochrome c and not through oxidative stress. 
This has been corroborated by the fi nding that CTN-
induced increase in caspase 3 catalytic activity could 
not be suppressed by antioxidants.
CTN reduces GSH levels in a dose- and time-
dependent manner in human alveolar epithelial cells 
A549 at non-toxic concentrations (60). This effect 
is the sign of oxidative stress and may contribute to 
infl ammation in people exposed to moulds.
GENOTOXICITY
Genotoxicity of CTN has not been unequivocally 
established because various test systems gave 
Table 2 Citrinin IC
50 






24 h 48 h 72 h
Human embryonic cell line (HEK293) - 120 80 25
Human promyelocytic leukemia (HL-60) cells 50 26
Porcine kidney PK15 68 27
Vero cells 220 28
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both positive and negative results. An increase in 
DNA damage was detected using single cell gel 
electrophoresis (comet test) in Vero cells exposed 24 h 
to CTN (28). However, the same method gave negative 
results in human-derived liver cells (HepG2) (61) and 
human embryonic kidney cells (HEK293) (25) no 
matter if Fpg was present or not. This suggests that 
CTN-induced oxidative stress did not affect DNA.
In contrast to negative results, various cell cultures 
exposed to CTN showed a signifi cant increase in 
micronucleus (MN) frequency. Twenty-four-hour 
exposure of PK15 cells to 30 µmol L-1 of CTN resulted 
in a signifi cant increase in MN frequency (9.5 ‰) over 
control (2.75 ‰) (27). This increase was also noticed 
in HEPG2 cells, human lymphocytes, and Chinese 
hamster V79 cells, but CTN concentrations showing 
genotoxicity differed between cell cultures (61-63).
MUTAGENICITY
CTN mutagenicity testing is also inconclusive. 
CTN was not mutagenic when tested with or without 
S9-mix (HepG2-derived enzyme homogenate) 
activation in TA-98 and TA-100 strains of Salmonella 
typhymurium (61). In another study, three additional 
strains (TA-1535, TA-1538 and TA-97) of S. 
typhymurium were used to test CTN mutagenicity (10), 
but no mutagenic effect was observed. However, when 
a primary hepatocyte culture was added, strain TA-
98 showed a signifi cant dose-dependent mutagenic 
response, and strain TA-100 a slight positive response. 
These results indicate that CTN requires a complex 
cellular biotransformation to become mutagenic.
Several studies have shown clastogenic CTN 
activity in vitro and in vivo, including a variety of 
chromosomal aberrations, save for sister chromatid 
exchange (SCE). In a study of Chinese hamster 
ovary cells and HEK293, CTN did not produce any 
signifi cant difference in either SCE frequency or DNA 
gaps and breaks (25).
Thust and Kneist established CTN-induced SCEs 
in Chinese hamster V79-E cells in the presence of 
S9-mix (64). They also observed the aneuploidic 
potential of CTN. CTN was found to be aneugenic 
because it caused concentration-dependent mitotic 
arrest, regardless of incubation time. This effect was 
reversible after the removal of CTN (64).
Jeswal (65) has found that CTN induces 
chromosome abnormalities and breaks in bone 
marrow cells in young weanling mice. The most 
frequent CTN-induced chromosome aberrations found 
in another study by Bouslimi et al. in bone marrow 
cells of adult mice included breaks, centric fusions, 
rings, and gaps (28).
CONCLUSIONS
Although CTN is a nephrotoxic compound in 
experimental animals, the mechanism of its toxicity 
is not fully understood. Combined with OTA, it may 
be involved in the aetiology of endemic nephropathy. 
However, little is known about human exposure to 
this mycotoxin through food because there is no legal 
obligation to measure it in Croatia or in the European 
Union.
Table 3 Citrinin LD
50
 values by way of administration and by experimental animal





/ mg kg-1 b.w. Reference
Rat M oral 50 30
Rat - s.c. 67 31
Rat - i.p. 67 31
Rat F, pregnant s.c. <35 32
Mouse M, BALB/C i.p. 45 28
Guinea-pig - i.p. 37 31
Rabbit Dutch Belted rabbit oral 134 33
Rabbit New Zealand White rabbit oral » 120 34
Rabbit - i.v. 19 31
Turkey M, 7 day-old oral 56 35
Pekin duck M, 7 day-old oral 57 35
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Citrinin (CTN) nefrotoksičan je mikotoksin koji proizvode različiti sojevi plijesni iz rodova Penicillium, 
Aspergillus i Monascus. CTN se može naći u različitim namirnicama biljnog podrijetla, osobito u žitaricama 
i obično se nalazi zajedno s drugim nefrotoksičnim mikotoksinom, okratoksinom A (OTA). Pretpostavlja se 
da je izloženost ovim mikotoksinima povezana s nastankom endemske nefropatije. Osim što je nefrotoksičan, 
CTN je još i embricidan i fetotoksičan. Na genotoksičnost citrinina upućuje pozitivan mikronukleusni 
test na različitim vrstama staničnih kultura, iako je kometski test negativan. Mutagenost CTN-a očituje 
se na različitim vrstama stanica samo ako se pridodaju stanični aktivatori kao npr. S9-mix. Mehanizam 
toksičnosti CTN-a nije potpuno razjašnjen pa još uvijek traje znanstvena rasprava je li njegova toksičnost 
i genotoksičnost posljedica oksidacijskog stresa ili povećane permeabilnosti mitohondrijskih membrana. 
U dostupnoj literaturi podaci o kontaminiranosti hrane i krmiva ovim mikotoksinom mnogo su rjeđi od 
onih za druge mikotoksine. Može se pretpostaviti da su ljudi često izloženi ovom mikotoksinu zato što ga 
proizvode iste plijesni koje proizvode i OTA, a one kontaminiraju hranu po cijelom svijetu.
U Hrvatskoj i u zemljama Europske Unije ne postoje zakonske odredbe o dopuštenim granicama CTN-a 
u bilo kojoj vrsti hrane.
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